BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 24362084)

  • 1. Looking back, to the future of circulating tumor cells.
    Friedlander TW; Premasekharan G; Paris PL
    Pharmacol Ther; 2014 Jun; 142(3):271-80. PubMed ID: 24362084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor cells: a multifunctional biomarker.
    Yap TA; Lorente D; Omlin A; Olmos D; de Bono JS
    Clin Cancer Res; 2014 May; 20(10):2553-68. PubMed ID: 24831278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating tumor cells: liquid biopsy].
    Alix-Panabières C; Pierga JY
    Bull Cancer; 2014 Jan; 101(1):17-23. PubMed ID: 24445939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack.
    Bulfoni M; Turetta M; Del Ben F; Di Loreto C; Beltrami AP; Cesselli D
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27783057
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicolor detection of rare tumor cells in blood using a novel flow cytometry-based system.
    Watanabe M; Uehara Y; Yamashita N; Fujimura Y; Nishio K; Sawada T; Takeda K; Koizumi F; Koh Y
    Cytometry A; 2014 Mar; 85(3):206-13. PubMed ID: 24327318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating tumor cells in lung cancer.
    Young R; Pailler E; Billiot F; Drusch F; Barthelemy A; Oulhen M; Besse B; Soria JC; Farace F; Vielh P
    Acta Cytol; 2012; 56(6):655-60. PubMed ID: 23207444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition.
    Lowes LE; Allan AL
    Adv Clin Chem; 2018; 83():121-181. PubMed ID: 29304900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics.
    Onstenk W; Gratama JW; Foekens JA; Sleijfer S
    Cancer Treat Rev; 2013 Nov; 39(7):691-700. PubMed ID: 23683721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis.
    Yokobori T; Iinuma H; Shimamura T; Imoto S; Sugimachi K; Ishii H; Iwatsuki M; Ota D; Ohkuma M; Iwaya T; Nishida N; Kogo R; Sudo T; Tanaka F; Shibata K; Toh H; Sato T; Barnard GF; Fukagawa T; Yamamoto S; Nakanishi H; Sasaki S; Miyano S; Watanabe T; Kuwano H; Mimori K; Pantel K; Mori M
    Cancer Res; 2013 Apr; 73(7):2059-69. PubMed ID: 23378342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating tumour cells and the epithelial mesenchymal transition in colorectal cancer.
    Lim SH; Becker TM; Chua W; Ng WL; de Souza P; Spring KJ
    J Clin Pathol; 2014 Oct; 67(10):848-53. PubMed ID: 25008452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer.
    O'Flaherty JD; Gray S; Richard D; Fennell D; O'Leary JJ; Blackhall FH; O'Byrne KJ
    Lung Cancer; 2012 Apr; 76(1):19-25. PubMed ID: 22209049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells as promising novel biomarkers in solid cancers.
    Lianidou ES; Strati A; Markou A
    Crit Rev Clin Lab Sci; 2014 Jun; 51(3):160-71. PubMed ID: 24641350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epithelial-mesenchymal transition: a hallmark in metastasis formation linking circulating tumor cells and cancer stem cells.
    Książkiewicz M; Markiewicz A; Zaczek AJ
    Pathobiology; 2012; 79(4):195-208. PubMed ID: 22488297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Essentials of circulating tumor cells for clinical research and practice.
    Liberko M; Kolostova K; Bobek V
    Crit Rev Oncol Hematol; 2013 Nov; 88(2):338-56. PubMed ID: 23830807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating tumor cells as "liquid biopsies" to understand cancer metastasis.
    Woo D; Yu M
    Transl Res; 2018 Nov; 201():128-135. PubMed ID: 30075099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal-Epithelial Transition and Circulating Tumor Cells in Small Cell Lung Cancer.
    Hamilton G; Rath B
    Adv Exp Med Biol; 2017; 994():229-245. PubMed ID: 28560677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technologies for label-free separation of circulating tumor cells: from historical foundations to recent developments.
    Jin C; McFaul SM; Duffy SP; Deng X; Tavassoli P; Black PC; Ma H
    Lab Chip; 2014 Jan; 14(1):32-44. PubMed ID: 23963515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of circulating tumor cells (CTCs) in newly-diagnosed and recurrent ovarian cancer patients.
    Liu JF; Kindelberger D; Doyle C; Lowe A; Barry WT; Matulonis UA
    Gynecol Oncol; 2013 Nov; 131(2):352-6. PubMed ID: 23954902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.